104 related articles for article (PubMed ID: 17711783)
1. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.
Serda RE; Adolphi NL; Bisoffi M; Sillerud LO
Mol Imaging; 2007; 6(4):277-88. PubMed ID: 17711783
[TBL] [Abstract][Full Text] [Related]
2. Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu H; Rajasekaran AK; Moy P; Xia Y; Kim S; Navarro V; Rahmati R; Bander NH
Cancer Res; 1998 Sep; 58(18):4055-60. PubMed ID: 9751609
[TBL] [Abstract][Full Text] [Related]
3. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
Kalambur VS; Longmire EK; Bischof JC
Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
5. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
Smirnov P
Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
[TBL] [Abstract][Full Text] [Related]
6. Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.
Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
Prostate; 2010 Sep; 70(12):1286-94. PubMed ID: 20623630
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
[TBL] [Abstract][Full Text] [Related]
8. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells.
Villanueva A; Cañete M; Roca AG; Calero M; Veintemillas-Verdaguer S; Serna CJ; Morales Mdel P; Miranda R
Nanotechnology; 2009 Mar; 20(11):115103. PubMed ID: 19420433
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
Funovics MA; Kapeller B; Hoeller C; Su HS; Kunstfeld R; Puig S; Macfelda K
Magn Reson Imaging; 2004 Jul; 22(6):843-50. PubMed ID: 15234453
[TBL] [Abstract][Full Text] [Related]
10. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
11. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
13. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO
Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
15. Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems.
Cheng CM; Chu PY; Chuang KH; Roffler SR; Kao CH; Tseng WL; Shiea J; Chang WD; Su YC; Chen BM; Wang YM; Cheng TL
Cancer Gene Ther; 2009 Jan; 16(1):83-90. PubMed ID: 18802451
[TBL] [Abstract][Full Text] [Related]
16. Expression of single-chain Fv gene specific for gamma-seminoprotein by RTS and its biological activity identification.
Han Y; Haun Y; Deng J; Gao F; Pan B; Cui D
Biotechnol Prog; 2006; 22(4):1084-9. PubMed ID: 16889383
[TBL] [Abstract][Full Text] [Related]
17. PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.
Tse BW; Cowin GJ; Soekmadji C; Jovanovic L; Vasireddy RS; Ling MT; Khatri A; Liu T; Thierry B; Russell PJ
Nanomedicine (Lond); 2015 Feb; 10(3):375-86. PubMed ID: 25407827
[TBL] [Abstract][Full Text] [Related]
18. [MR imaging of embryonic stem cells labeled by superparamagnetic iron oxide].
Wang B; Jaconi M; Li J; Wang Y; Valle JP
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1646-8. PubMed ID: 17803860
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer.
Abdolahi M; Shahbazi-Gahrouei D; Laurent S; Sermeus C; Firozian F; Allen BJ; Boutry S; Muller RN
Contrast Media Mol Imaging; 2013; 8(2):175-84. PubMed ID: 23281290
[TBL] [Abstract][Full Text] [Related]
20. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles.
Artemov D; Mori N; Okollie B; Bhujwalla ZM
Magn Reson Med; 2003 Mar; 49(3):403-8. PubMed ID: 12594741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
